KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Assets Average: 2019-2025

Historic Assets Average for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to $24.7 billion.

  • BioNTech SE's Assets Average rose 1.84% to $24.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 billion, marking a year-over-year increase of 1.84%. This contributed to the annual value of $24.4 billion for FY2024, which is 0.67% up from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Assets Average is $24.7 billion, which was up 5.70% from $23.4 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Assets Average ranged from a high of $24.7 billion in Q3 2025 and a low of $3.9 billion during Q1 2021.
  • For the 3-year period, BioNTech SE's Assets Average averaged around $24.1 billion, with its median value being $24.2 billion (2023).
  • Its Assets Average has fluctuated over the past 5 years, first surged by 905.48% in 2021, then declined by 5.26% in 2025.
  • BioNTech SE's Assets Average (Quarterly) stood at $17.4 billion in 2021, then surged by 33.54% to $23.3 billion in 2022, then grew by 5.00% to $24.5 billion in 2023, then fell by 0.51% to $24.3 billion in 2024, then climbed by 1.84% to $24.7 billion in 2025.
  • Its Assets Average was $24.7 billion in Q3 2025, compared to $23.4 billion in Q2 2025 and $23.2 billion in Q1 2025.